Our results indicated that overexpression of FBXW8 mRNA was significantly associated with better prognosis in luminal A and basal-like BC patients, however, it was correlated with worse survival in HER2-overexpressiong BC patients. The gene discussed is FBXW8; the disease is breast cancer.